| Identification | Back Directory | [Name]
S32826 | [CAS]
1096770-84-1 | [Synonyms]
OUXAHVRWFHOKHY-UHFFFAOYSA-N
S32826 disodium salt hydrate
4-Tetradecanamidobenzylphosphonic acid
[4-(Tetradecanoylamino)benzyl]phosphonic acid
Phosphonic acid, P-[[4-[(1-oxotetradecyl)amino]phenyl]methyl]-
[4-(Tetradecanoylamino)benzyl]phosphonic acid disodium salt hydrate | [Molecular Formula]
C21H36NO4P | [MDL Number]
MFCD12761322 | [MOL File]
1096770-84-1.mol | [Molecular Weight]
397.49 |
| Chemical Properties | Back Directory | [density ]
1.116±0.06 g/cm3(Predicted) | [storage temp. ]
-20°C | [solubility ]
H2O: ≥10mg/mL | [form ]
powder | [pka]
2.24±0.10(Predicted) | [color ]
white | [Water Solubility ]
H2O: ≥10mg/mL | [InChI]
1S/C21H36NO4P.2Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-21(23)22-20-16-14-19(15-17-20)18-27(24,25)26;;/h14-17H,2-13,18H2,1H3,(H,22,23)(H2,24,25,26);;/q;2*+1/p-2 | [InChIKey]
DGRFALMFDGBLCP-UHFFFAOYSA-L | [SMILES]
[Na+].[Na+].CCCCCCCCCCCCCC(=O)Nc1ccc(CP([O-])([O-])=O)cc1 |
| Hazard Information | Back Directory | [Uses]
S32826, a potent inhibitor of autotaxin (ATX), may be used to identify and characterize the lyso-phospholipase D (lysoPLD, ATX) involved in bioactive lyso-phosphatidic acid (LPA) formation. S32826 may be used to help determine the role of ATX in malignant cell processes such as tumorigenesis, invasion, and metastases; cardia bifida and atherosclerosis. | [Definition]
ChEBI: P-[[4-[(1-oxotetradecyl)amino]phenyl]methyl]-phosphonic acid is an anilide. | [Biological Activity]
S32826 is a potent inhibitor of autotaxin. Autotaxin is a newly discovered lyso-phospholipase D (lysoPLD). Autotaxin and lyso-phosphatidic acid (LPA) have been associated with early cancer progression and motility of cancer cells as well as with metastasis. Because of localization (adipose tissue)the enzyme might play an important role in diabetes and obesity. Autotaxin might be the only source of LPA. S32826 is the strongest inhibitor of autotaxin reported. The compound shows activity in cellular or ex vivo models. |
|
|